S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20
S&P 500   4,594.62
DOW   34,899.34
QQQ   391.20

Genesis Healthcare Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
50-Day Range
52-Week Range
125,124 shs
Average Volume
7.52 million shs
Market Capitalization
$35.03 million
P/E Ratio
Dividend Yield

Receive GEN News and Ratings via Email

Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Genesis Healthcare logo

About Genesis Healthcare

Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.


See More Headlines

Industry, Sector and Symbol

Skilled nursing care facilities
Year Founded

Sales & Book Value

Annual Sales
$4.57 billion
Book Value
($6.57) per share


Net Income
$14.62 million
Pretax Margin




Free Float
Market Cap
$35.03 million

Company Calendar

Last Earnings


Overall MarketRank

1.77 out of 5 stars

Medical Sector

853rd out of 1,391 stocks

Skilled Nursing Care Facilities Industry

2nd out of 3 stocks

Analyst Opinion: 2.5Community Rank: 4.7Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

Is Genesis Healthcare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street analysts is that investors should "sell" Genesis Healthcare stock.
View analyst ratings for Genesis Healthcare
or view top-rated stocks.

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) posted its earnings results on Monday, November, 9th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.02) by $0.53. The firm earned $938.65 million during the quarter. Genesis Healthcare had a negative trailing twelve-month return on equity of 5.06% and a negative net margin of 1.52%.
View Genesis Healthcare's earnings history

What price target have analysts set for GEN?

1 brokers have issued 1-year target prices for Genesis Healthcare's stock. Their forecasts range from $0.57 to $0.57. On average, they expect Genesis Healthcare's stock price to reach $0.57 in the next twelve months.
View analysts' price targets for Genesis Healthcare
or view top-rated stocks among Wall Street analysts.

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:
  • Mr. Robert H. Fish, CEO & Director (Age 70, Pay $411.5k)
  • Mr. Thomas DiVittorio, Exec. VP & CFO (Age 53, Pay $565k)
  • Mr. Paul David Bach, COO & Exec. VP (Age 62, Pay $630k)
  • Mr. Stephen Scott Young, Chief Accounting Officer & Treasurer (Age 49)
  • Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 66)
  • Mr. James W. Tabak, Sr. VP of Admin. & Gov. Affairs (Age 62)
  • Ms. Lori Mayer, VP of Investor Relations, Brand Management & Marketing Communications
  • Mr. Michael Scott Sherman, Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer (Age 52)
  • Mr. Larry Baider, Sr. VP of People Strategy & Operations
  • Dr. JoAnne Susan Reifsnyder R.N., Ph.D., Ph.D., ACHPN, MSN, MBA, RN, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 62)

Who are some of Genesis Healthcare's key competitors?

What other stocks do shareholders of Genesis Healthcare own?

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How much money does Genesis Healthcare make?

Genesis Healthcare has a market capitalization of $0.00 and generates $4.57 billion in revenue each year.

How many employees does Genesis Healthcare have?

Genesis Healthcare employs 44,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

Where are Genesis Healthcare's headquarters?

Genesis Healthcare is headquartered at 101 EAST STATE STREET, KENNETT SQUARE PA, 19348.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected].

This page was last updated on 11/28/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.